Chembond Chemicals Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Published 31 May 2026 | Chemicals & Petrochemicals | Market Cap: ₹615 Cr

Company aspires to reach ₹1000 crore sales within four years, aiming for nearly triple current sales (~₹330-340 crores). The company aims to triple sales to ₹1000 crores within four years through geographical expansion, new market activation, and organic growth.

From Chembond Chemicals Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Price

284

Market Cap

₹615 Cr

P/E Ratio

16.1

Revenue Rank

Rank 3

Margin Rank

Rank 3

How does Chembond Chemicals Ltd rank in Chemicals & Petrochemicals?

Compare Chembond Chemicals Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.

Revenue: Rank 3Margin: Rank 3
View Chemicals & Petrochemicals leaderboard →

Chembond Chemicals Ltd — Quarterly revenue & net profit

Revenue Net Profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹101 Cr, net profit ₹12 Cr.

Full financials →

📊 Revenue & Sales Performance

Rank 3
  • Company aspires to reach ₹1000 crore sales within four years, aiming for nearly triple current sales (~₹330-340 crores).
  • Growth strategies include geographical expansion, entering new markets, and organic growth from a larger base.
  • Volume growth drives most sales increases; price increases have contributed minimally.
  • Construction chemicals volume growth forecasted at 15-20%, water chemicals around 10% for the current year.
  • Water business shows fastest growth and strong order book, with new client additions driving volume increases.
  • Distribution and cleaning & hygiene businesses showing positive growth due to team realignment and product additions.
  • Despite some margin pressure due to input cost inflation, long-term growth momentum is expected to continue, supported by industry growth and new business wins.

📈 Profitability & Margins

Rank 3
  • The company aims to triple sales to ₹1000 crores within four years through geographical expansion, new market activation, and organic growth.
  • Volume growth is expected to drive sales, with construction chemicals projected at 15-20% and water chemicals around 10% volume growth.
  • EBITDA margins may face slight pressure (~3%) due to input cost volatility but could stabilize as higher-priced contracts are locked in.
  • Profit growth is linked closely to sales volume increases and operational efficiencies rather than price hikes, as price growth contributed minimally historically.
  • The water business remains the largest contributor (~85-87%), with plans to reduce its share by growing other segments faster, diversifying revenue streams.
  • Integration of cleaning & hygiene and water treatment technologies is expected to improve margins and growth trajectory.
  • Overall, earnings and profits are forecasted to improve steadily with sales growth, despite temporary margin pressures from raw material cost fluctuations.

🏗️ Capital Expenditure Plans

Yes
  • Current year CAPEX has increased to around ₹20-21 crores, mainly due to the full-year impact of the demerger, including assets transferred to their books and office building renovations.
  • Preparing for potential adverse scenarios with readiness for all eventualities.
  • No plans for major new plant setups or large-scale capital investments beyond current year CAPEX.
  • Intend to deploy some funds in network growth and geographical expansion.
  • Focus on expanding existing capacity and improving infrastructure rather than greenfield projects currently.

💰 Fundraising & Capital Structure

No information
  • No immediate plans for new fundraising through debt or equity.
  • The company is currently preparing for worst-case scenarios due to uncertain market conditions.
  • Available funds (around Rs. 65 crores) are planned to be deployed for network growth and geographical expansion.
  • No major additional plant or CapEx deployment beyond the current year is planned at this time.

📋 Order Book & Pipeline

Yes
  • The Water Business Unit (BU) is entering the period with a strong order book for both chemicals and equipment.
  • There are ongoing activities and developments in the bioremediation space, with expectations of increased contributions from the wastewater treatment subsection.
  • New client additions have driven volume growth in the water chemicals business, with contracts extending till mid of the current financial year.
  • Several public sector contracts have come up for tendering, with bids already submitted at higher prices.
  • The company is actively pursuing new market opportunities and expanding geographically to increase its order book.

Key Metrics

Revenue

Rank 3

Margin

Rank 3

Capex

Yes

Fundraise

No information

Order Book

Yes

Frequently Asked Questions

What were Chembond Chemicals Ltd Q4 FY26 results?

Company aspires to reach ₹1000 crore sales within four years, aiming for nearly triple current sales (~₹330-340 crores). The company aims to triple sales to ₹1000 crores within four years through geographical expansion, new market activation, and organic growth.

What is Chembond Chemicals Ltd share price analysis?

Chembond Chemicals Ltd currently shows a below-average growth signal. The stock trades at a P/E of 16.1 with a market cap of ₹615 Cr. Investors should review the full earnings analysis for detailed insights.

Is Chembond Chemicals Ltd planning capital expenditure?

Current year CAPEX has increased to around ₹20-21 crores, mainly due to the full-year impact of the demerger, including assets transferred to their books and office building renovations.

Keep Chembond Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

What Chembond Chemicals Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Rossari Biotech (Q4 FY26)

    50-70 crore planned for FY27 focused on pharma and aroma chemical facilities to support value-added product segments. Key concall takeaways from Rossari…

  • Pidilite Inds. (Q4 FY26)

    Underlying volume growth (UVG) averaged over 9% per quarter last year, with a ~200 bps increase in FY '25; the company plans to continue lifting UVG…

  • PCBL Chemical (Q4 FY26)

    The company has reduced overall borrowings by approximately INR 450 crores in the current year. Key concall takeaways from PCBL Chemical's Q4 FY26 earnings…

  • Aarti Industries (Q4 FY26)

    Capex planned around INR750-800 crore in FY27, mainly for Zone IV completion and new long-term contracts, supporting medium-term growth. Key concall takeaways…